Ocugen (OCGN) – Raising Price Target After Positive OCU410 Data Reported


Wednesday, March 25, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Top-Line Phase 2 ArMaDa Trial Data Reported. Ocugen reported Phase 2 data for OCU410, its gene therapy for geographic atrophy in dry age-related macular degeneration (GA-dAMD). The data shows clinically meaningful and statistically significant benefit of 31% for treated patients compared with placebo. Based on the trial results, we are including OCU410 revenues in our FY2029 earnings model and raising our price target to $12 per share.

Results Show Preservation of Function and Cell Structure. The primary endpoint showed 31% reduction in lesion growth at the optimal dose (medium) group compared to controls (p< 0.05). A secondary endpoint of photoreceptor cell loss, correlating with visual function, showed a 27% slower rate compared to controls. In addition, 55% of treated patients demonstrated a lesion size reduction of greater than 30% compared with controls.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

First Phosphate Corp. (FRSPF) – NRCan Contribution Agreement Signed; Funding Secured


Wednesday, March 25, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Investor webinar. CEO John Passalacqua recently presented to investors via Simone Capital. During the call, Mr. Passalacqua commented on the signed contribution agreement with Natural Resources Canada, the ongoing drill program and future feasibility study, the ADR launch, and the strength of the stock in recent weeks relative to a difficult broader market. Management attributed the stock’s resilience to the quality of the shareholder base, consistent milestone execution, and the visible de-risking effect of government backing.

NRCan contribution agreement signed. First Phosphate has executed a formal agreement with Natural Resources Canada providing up to C$16.7 million in non-repayable government funding under the Global Partnerships Initiative. The structure is a reimbursement model, whereby the company incurs eligible expenditures and receives reimbursement of up to 75% within approximately three months, supporting technical and engineering validation work through 2028. Combined with approximately C$20-C$22 million in cash on hand, we estimate total accessible financial resources of approximately C$36-C$38 million, sufficient to fund the company through drill completion, feasibility study, and final investment decision.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Bitcoin Depot (BTM) – Leadership Reset Amid Regulatory Pressure and Revenue Diversification Efforts


Wednesday, March 25, 2026

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Leadership transition introduces seasoned external operator. The company announced that CEO Scott Buchanan has stepped down effective March 23, 2026, with founder Brandon Mintz stepping down as Executive Chairman and remaining on the Board in an advisory capacity. The Board appointed Alex Holmes as CEO and Chairman. Mr. Holmes brings relevant experience from his tenure as CEO of MoneyGram, particularly in payments infrastructure and regulatory compliance.

Transition comes at a pivotal time for the business. The leadership changes follow a quarter impacted by regulatory headwinds and ahead of a guided 30% to 40% decline in core BTM revenue in 2026. At the same time, the company is beginning to pursue new business initiatives, including its expansion into peer-to-peer betting and merchant cash advances. While the company noted the departures were not due to disagreements, in our view, the timing suggests the Board may be positioning the company for its next phase of execution as it navigates both regulatory pressure and early-stage diversification efforts.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Comstock (LODE) – Review of 2025 and Outlook for 2026


Wednesday, March 25, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A year of repositioning. During 2025, Comstock Inc. repositioned itself around two scalable growth businesses: Comstock Metals, which targets solar panel recycling and critical mineral recovery, and its investment in Bioleum Corporation, which is advancing biomass-based renewable fuels.

Near-term revenue visibility. Comstock Metals represents the most immediate catalyst for value creation. Comstock has validated a zero-landfill solar panel recycling process and completed permitting for its first industry-scale facility in Nevada, with operations expected to commence in the second quarter of 2026. The company has also secured logistics infrastructure and customer agreements across key U.S. regions, reflecting growing demand for end-of-life solar panel processing. Over time, the strategy could include multiple facilities and integrated refining capabilities that target recovery of higher-value metals such as silver.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Banzai’s Bold Bet: Microcap MarTech Player Eyes Revenue-Doubling Acquisition of ConnectAndSell

Banzai International (Nasdaq: BNZI) just made a move that could fundamentally reshape what the microcap marketing technology company looks like by summer — and the numbers tell a striking story.

The Austin-based AI marketing platform announced late last week that it has reached terms to acquire the assets of ConnectAndSell, an AI-powered sales acceleration platform serving B2B organizations across healthcare, financial services, and technology. The deal, structured around a non-binding letter of intent, is expected to close in early Q2 2026, pending a definitive agreement and customary closing conditions.

The strategic rationale is straightforward on paper: Banzai recorded approximately $10.65 million in revenue over the trailing twelve months ending Q3 2025. The ConnectAndSell acquisition is projected to add roughly $15 million in annual revenue — meaning the deal alone would more than double the company’s current revenue run rate if integration goes according to plan. For a company with a market cap hovering around $14 million, that kind of top-line expansion isn’t incremental — it’s transformational.

ConnectAndSell is not a startup. It is an established, profitable business with a track record of generating real revenue across enterprise and mid-market accounts. Its platform is designed to dramatically increase sales team productivity by maximizing time spent in live conversations with qualified decision-makers — a capability that sits at the highest-value stage of the go-to-market funnel. For Banzai, which already helps companies target, engage, and measure marketing outcomes, layering in sales execution capabilities creates an end-to-end revenue platform that few companies at this market cap can claim.

The deal follows Banzai’s acquisition of Superblocks in November 2025, an agentic AI platform for SEO-optimized website development. The pattern is becoming clear: Banzai is pursuing a deliberate build-out strategy, acquiring profitable, AI-native tools that are immediately accretive and strategically complementary rather than chasing speculative moonshots.

Cross-sell opportunity is a core part of the investment thesis here. Banzai’s existing customer base includes more than 140,000 organizations — among them RBC, Dell Technologies, New York Life, and Thermo Fisher Scientific. Introducing ConnectAndSell’s sales acceleration capability to even a fraction of that base could generate meaningful incremental revenue beyond the $15 million headline figure.

Still, investors should keep a few realities in check. The transaction remains at the letter of intent stage — no definitive agreement has been signed, and no purchase price has been disclosed, creating near-term financial transparency uncertainty. Banzai’s stock has also declined roughly 89% over the past year, sitting just below the $1 mark, which reflects a company that has been fighting uphill on the balance sheet even as it executes strategically. Management is scheduled to discuss the proposed acquisition in detail on a conference call March 31, 2026 at 4:30 p.m. Eastern Time, which will be the next critical data point for investors watching this deal develop.

For small and microcap investors, Banzai’s acquisition playbook is worth watching. In a market where platform consolidation is increasingly the path to survival and scale, companies that can string together profitable, AI-powered assets at reasonable valuations may be positioning themselves for an outsized rerating when the market conditions turn. Whether BNZI can execute on that vision is the question the rest of 2026 will answer.

GDEV (GDEV) – Improved Profitability Appears Sustainable


Tuesday, March 24, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Solid Q4 results. The company reported Q4 revenue of $90.0 million and adj. EBITDA of $15.0 million. While revenue was modestly below our estimate of $99.0 million, adj. EBITDA was in line with our estimate of $15.1 million. Notably, the strong adj. EBITDA figure was largely driven by more efficient use of marketing spend, which decreased approximately 25% compared to the prior year period.

Key operating metrics. Bookings and monthly paying users (MPU) decreased by 7% and 10%, respectively, compared with the prior year period, but the decrease was expected as the company is focused on the quality of gameplay and retaining high-quality users. Furthermore, the company’s strategy appears to be paying off, as average bookings per paying user (ABPPU) increased from $102 in Q4’24 to $106 in Q4’25.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Circle Stock Craters 20% as Clarity Act’s Stablecoin Yield Language Rattles Crypto Markets

Circle Internet Group (CRCL) suffered its steepest single-session decline since going public on Tuesday, plunging as much as 20% after reports surfaced that the latest draft of the Digital Asset Market Clarity Act contains language that could severely restrict stablecoin yield programs — a business model central to how Circle and its partners generate revenue.

Coinbase (COIN), Circle’s primary distribution partner for its USDC stablecoin, fell roughly 8% in sympathy. The Circle-Coinbase revenue-sharing arrangement is a key reason Coinbase is directly exposed to any regulatory changes affecting USDC economics.

What the Clarity Act Says — and Why It Matters

The latest version of the Clarity Act, shaped by a compromise crafted by Senators Angela Alsobrooks and Thom Tillis, would ban yield payments for simply holding a stablecoin. Industry insiders who got their first look at the revised draft on Monday described the language as overly narrow and unclear, creating significant uncertainty for platforms that have built yield-based products around stablecoins.

The compromise would allow rewards programs tied to a user’s stablecoin activity, but not their balance — a meaningful distinction that would effectively prohibit programs that function like interest-bearing deposit accounts.

This is not a brand-new fight. The banking lobby has pushed hard to restrict stablecoin yield because yield-bearing stablecoins would functionally compete with savings accounts — if a stablecoin issuer offered 4% on a digital dollar balance, consumers have little incentive to park money in a traditional 0.5% checking account. Congress, through the GENIUS Act signed into law last July, already prohibited stablecoin issuers from paying yield directly. The Clarity Act debate is now about whether third-party platforms — like Coinbase — can offer those returns as an intermediary.

The OCC, in its proposed rulemaking to implement the GENIUS Act, suggested that close financial ties between stablecoin issuers and crypto platforms handling their tokens would make it highly likely that any yield paid through an intermediary constitutes an attempt to evade the GENIUS Act’s prohibition. That regulatory posture adds a second layer of pressure on the Circle-Coinbase model even before the Clarity Act is finalized.

Circle’s Recent Run — and the Reversal

The selloff comes after an extraordinary run for Circle shares. The stock rallied approximately 110% from around $60 in late February to a high of roughly $130 just last week, driven by strong quarterly results, explosive USDC circulation growth, and expectations that the Federal Reserve will hold rates steady — a key input since Circle generates the bulk of its revenue from interest earned on the Treasury-backed reserves underpinning USDC.

The company has also been expanding its footprint beyond stablecoin issuance. Last year, Circle launched Arc, a specialized blockchain designed to support global payments, foreign exchange, and tokenized real-world assets using USDC as its native currency — a bid to position itself as a broader fintech infrastructure play.

The Stakes for the Broader Crypto Ecosystem

Though the crypto industry scored a major win when the GENIUS Act became the first major U.S. law to govern a segment of the crypto industry, it was designed as the first step of a two-part policy approach, with the Clarity Act meant to be the more consequential full-fledged framework for digital assets.

Stablecoin yield has become the single largest sticking point standing between the crypto industry and that comprehensive regulatory framework. Until Tuesday’s language leak, markets had been pricing in a favorable resolution. That assumption just took a significant hit.

Trump Pays a French Energy Giant to Exit U.S. Offshore Wind — and Redirects the Money to Fossil Fuels

The Trump administration has agreed to refund $1 billion in offshore wind lease fees to French energy giant TotalEnergies, effectively paying the company to abandon two major U.S. wind projects and redirect that capital into oil, gas, and liquefied natural gas development. The move marks one of the most aggressive — and costly — steps yet in the administration’s campaign to dismantle the offshore wind industry built up under the Biden era.

The Department of Interior announced Monday that TotalEnergies will surrender its leases for planned offshore wind projects off the coasts of North Carolina and New York. In exchange, the company will receive reimbursement up to the full amount it paid to acquire those leases. TotalEnergies has also pledged not to pursue any new offshore wind development in the United States. The refunded capital will be redirected toward the construction of a liquefied natural gas facility in Texas and the expansion of the company’s broader U.S. oil and gas portfolio.

For context, TotalEnergies paid roughly $133,000 for the North Carolina lease and approximately $795,000 for the New York and New Jersey lease — both purchased in 2022 during the height of the Biden administration’s offshore wind push. The Carolina Long Bay project had been designed to generate over one gigawatt of power, enough to supply roughly 300,000 homes. The New York project was even larger, with a planned capacity of three gigawatts capable of powering close to one million homes.

The deal raises immediate questions about the use of public funds. Environmental advocates were quick to characterize it as taxpayer money being spent to eliminate clean energy capacity rather than build it — particularly at a moment when the Iran conflict has sent oil prices surging and renewed global debate about energy security and diversification.

This transaction also comes after the administration’s earlier attempts to halt offshore wind construction were struck down by federal courts. Judges overturned executive orders that had targeted five major East Coast wind projects on national security grounds, allowing construction to continue. The TotalEnergies deal appears to signal a strategic pivot — using financial settlements to achieve what legal orders could not.

The broader energy policy picture is shifting rapidly. Ironically, on the same day this deal was announced, one of the offshore wind farms previously targeted by the administration — Coastal Virginia Offshore Wind — began delivering power to the Virginia grid. The developer, Dominion Energy, confirmed the milestone, underscoring the fact that the offshore wind industry, despite significant political headwinds, continues to advance.

For investors in the small and microcap energy space, the implications cut both ways. Companies with exposure to LNG infrastructure, domestic oil and gas development, and fossil fuel supply chains stand to benefit from the administration’s policy direction and capital reallocation. On the other side, smaller renewable energy developers and wind supply chain companies face an increasingly hostile regulatory and financial environment in the U.S., even as offshore wind capacity expands globally — with China leading the world in new installations.

The $1 billion question is whether this deal represents a one-time settlement or the beginning of a broader pattern of government-funded exits from the U.S. renewable energy sector.

Small Caps Surge 3% as Iran Talks Spark One of the Market’s Best Single-Day Reversals

The small-cap market opened Monday in the crosshairs of a global selloff, only to stage one of its most dramatic single-session recoveries in recent memory — all within the span of a few hours. The whipsaw move underscores just how vulnerable smaller, domestic-focused companies have become to the escalating conflict in the Middle East, and how quickly sentiment can shift on a presidential comment.

Going into this week, the Russell 2000 — the primary benchmark for small-cap equities — had already shed more than 7% in March alone, entering official correction territory last Friday with a decline exceeding 10% from its recent peak. The index, which had started the year as a market leader riding optimism around rate cuts and a rotation away from mega-cap tech, has now given back virtually all of those gains. As of last Thursday, the index’s year-to-date return had collapsed to less than 1%.

The catalyst for the unraveling has been the ongoing U.S.-Israel conflict with Iran. Since military operations began, Brent crude futures surged more than 40%, briefly touching $119 per barrel before pulling back. The ripple effects have been severe for small caps specifically. Unlike large-cap multinationals with diversified revenue streams and investment-grade credit, smaller companies are more exposed to rising input costs, tighter credit markets, and slowing consumer demand — the exact cocktail that an oil shock delivers.

The pain goes deeper than sentiment. Analysts now estimate that between 41% and 46% of Russell 2000 companies are unable to cover their interest expenses with operating income. These so-called zombie companies face a $368 billion debt maturity wall in 2026, and with the 10-year Treasury yield spiking to 4.38% by Friday — up sharply from the mid-3% range at the start of the year — refinancing that debt is significantly more expensive. The Federal Reserve’s decision to hold rates steady at 3.50%–3.75% at its March 18th meeting, while revising its inflation outlook upward, effectively removed any near-term cushion the market was counting on.

Then came Monday’s reversal.

Overnight, global markets were in freefall. South Korea’s KOSPI dropped over 6%, Japan’s Nikkei fell more than 3%, and European equities opened deep in the red. U.S. futures pointed to a fifth consecutive down week for American stocks. But within the first hour of trading, the picture changed completely. President Trump signaled he was postponing threatened strikes on Iranian power infrastructure, citing productive negotiations. Brent crude fell more than 10% on the news. U.S. equities surged, with the Russell 2000 climbing more than 3% intraday — one of the index’s strongest single-day moves of the year — reclaiming the 2,500 level.

For small-cap investors, this session captures exactly what makes the asset class both compelling and treacherous. Bank of America has noted that while the Russell 2000 tends to sell off more sharply than large caps in risk-off environments, it also tends to recover faster — historically outpacing large caps by more than a percentage point within three months of a geopolitical shock.

The Iran situation is far from resolved. But today’s action is a reminder that in small caps, the most dangerous moments often precede the most significant opportunities.

Eledon Pharmaceuticals (ELDN) – FY2025 Reported With Tegoprubart Updates and Phase 3 Expectations


Monday, March 23, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Tegoprubart Trials To Advance In FY2026. Eledon reported a 4Q loss of $10.4 million or $(0.11) per share and a FY2025 loss of $45.6 million or $(0.52) per share. The FY Total Operating Expenses were $83.3 million, with non-cash items (including changes in the fair value of warrant liabilities) of $33.4 million. Net Loss excluding these items would have been $79.1 million for full year. Updates for tegoprubart clinical development were also confirmed with the announcement. Cash on December 31, 2025 was $45.6 million.

Clinical Trials In Transplantation Have Several Milestones Ahead. Eledon expects to meet with the FDA to discuss plans for a Phase 3 tegoprubart trial for prevention of kidney transplant rejection. We expect the guidance to clarify required endpoints and could lead to the start of Phase 3 by year-end. Guidance is also expected for Islet cell transplantation in diabetes and xenotransplantation.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Titan International (TWI) – Production Consolidation


Monday, March 23, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Consolidation. Last week, Titan announced a decision to consolidate production within its North American manufacturing footprint, which will result in the closure of its manufacturing facility in Jackson, Tennessee, by the end of October 2026. The Company expects production currently performed in Jackson to be transitioned to other existing Titan facilities over the coming months. We view this action as part of the Company’s ongoing efforts to optimize its manufacturing footprint and improve capacity utilization, given the uncertain operating environment.

Details. The Jackson closure is part of the ongoing synergies the Company expected to deliver from the Carlstar acquisition. The one-time costs for the plant closure and manufacturing relocation are estimated to be in the $7 million range, likely to hit in relatively equal amounts over the next three quarters. Estimated annual savings are in the $5 million range, with the full amount likely to begin in 2027.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

1-800-Flowers.com (FLWS) – Raising Rating: Unleashing AI To Drive Efficiency And Growth


Monday, March 23, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Highlights from a fireside chat. This report highlights a fireside chat with Adolfo Villagomez, CEO, who discussed the company’s four pillar initiative to transform the company into a more efficient, growth focused company. 

Improving the company’s cost structure. Management has implemented a comprehensive review of the organization’s operations with the goal of reducing redundancies and improving productivity. The company is targeting approximately $50 million in run-rate cost savings across fiscal years 2026 and 2027, achieved through initiatives such as workforce streamlining, supply chain optimization, procurement improvements, and the reduction of organizational layers.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Gold Just Had Its Worst Week Since 1980 — Here’s the Uncomfortable Reason Why

For decades, the playbook has been simple: when war breaks out, buy gold. But the ongoing U.S.-Israeli conflict with Iran is rewriting that script in real time, and investors are scrambling to make sense of a metal that is behaving more like a speculative trade than the world’s oldest store of value.

Gold has dropped nearly 10% this week, putting it on track for its worst weekly performance in 43 years, with the metal’s total decline since the war began now sitting at approximately 13%. On Friday, gold was trading around $4,570 per troy ounce — erasing two months of gains in a matter of days.

The Rate Problem Nobody Saw Coming

The paradox at the heart of gold’s collapse is this: the same war that should theoretically be sending investors rushing into safe-haven assets is also the reason central banks are slamming the door on interest rate cuts.

The Federal Reserve held rates steady and cited uncertain impacts from the conflict, while the Bank of Japan kept rates unchanged, noting that inflation risks are now tilted to the upside. Central banks across Europe — including the U.K. and the eurozone — followed suit. Market expectations for Fed rate cuts have shifted dramatically, with traders now pricing in no cuts until as late as June 2027 — a full twelve months later than pre-war projections. That matters enormously for gold, which pays no yield. When bonds and other interest-bearing assets become more attractive, gold loses its competitive edge almost immediately.

The Dollar Is Doing Gold No Favors Either

The U.S. dollar has rebounded approximately 2.2% since the Iran war began, halting a months-long slide. Because gold is priced in dollars, a stronger greenback makes the metal relatively more expensive for international buyers, dampening global demand.

Oil prices have remained above $100 per barrel following attacks on major energy infrastructure, including one of the world’s largest natural gas fields shared by Iran and Qatar, with the conflict showing no signs of resolution. Energy-driven inflation is now feeding directly into the rate calculus that is punishing gold.

From Safe Haven to Meme Trade — and Back?

Part of what’s happening is a hangover from an extraordinary run. Gold surged 66% in 2025, its best annual performance since 1979, before hitting $5,000 per troy ounce for the first time in January 2026. Retail investors piled in chasing momentum, and when that momentum began to reverse, the selling accelerated. Some analysts have raised the possibility that central banks, which were previously aggressive buyers, may now be turning into net sellers — an additional headwind few had anticipated.

The longer-term bull case hasn’t disappeared. J.P. Morgan maintains a 2026 year-end target of $6,300 per ounce, while Deutsche Bank holds firm at $6,000 — though both forecasts were set before the Iran escalation.

For long-term holders, the fundamental case remains intact. Real interest rates, global monetary policy, and persistent geopolitical uncertainty have historically been the primary drivers of sustained gold bull markets, and none of those underlying forces have been resolved.

The question isn’t whether gold’s story is over. The question is whether the market has finally priced in a world where geopolitical chaos and monetary tightening can coexist — and where gold, at least temporarily, is caught in the crossfire.